Hollywood et al. established human iPSCs-derived kidney organoids with CTNS deficiency that reflect key proximal tubular phenotypes of cystinosis, including cystine accumulation, lysosomal enlargement, defective autophagic flux, and increased apoptosis, and further identified combined cysteamine and mTOR inhibition as a potential therapeutic strategy [89]. This evidence concerns the gene MTOR and cystinosis.